EY Appoints Pamela Spence To Global Life Sciences Industry Leader
LONDON, 20 JULY 2016. EY announces the appointment of Pamela Spence to the role of Global Life Sciences Industry Leader to its Global Life Sciences sector practice.
Pamela assumes her new role with nearly 20 years’ experience working with clients across the life sciences and health care sectors. Since joining EY in 1998, she has held leadership positions in Transaction Advisory Services within the health sciences and technology sectors. During this time she led multinational transactions, acquisitions, disposals and IPOs, in addition to holding roles in business development with a focus on the life sciences sector. Prior to this appointment, Pamela was the global lead partner for some of EY’s largest multinational life sciences clients.
With a background in organic chemistry, earning a BSc (Hons) in Chemistry from the University of Nottingham, UK, Pamela is a qualified chartered accountant and has also attended INSEAD and Northwestern University's Kellogg School of Management.
Within this role, Pamela will continue to serve on the EY Global Accounts Committee, which is responsible for setting the strategic direction of the global organization's largest multinational clients across all industry sectors. Throughout her career at EY Pamela has distinguished herself as a passionate leader and as an advocate for diversity and inclusiveness, and these qualities will help to ensure a smooth transition as she moves into her new role. She will continue to be based in London.
Pamela Spence, EY Global Life Sciences Industry Leader, says: the life sciences sector. Prior to this appointment, Pamela was the global lead partner for some of EY’s largest multinational life sciences clients.
With a background in organic chemistry, earning a BSc (Hons) in Chemistry from the University of Nottingham, UK, Pamela is a qualified chartered accountant and has also attended INSEAD and Northwestern University's Kellogg School of Management.
Within this role, Pamela will continue to serve on the EY Global Accounts Committee, which is responsible for setting the strategic direction of the global organization's largest multinational clients across all industry sectors. Throughout her career at EY Pamela has distinguished herself as a passionate leader and as an advocate for diversity and inclusiveness, and these qualities will help to ensure a smooth transition as she moves into her new role. She will continue to be based in London.
Pamela Spence, EY Global Life Sciences Industry Leader, says:
“This is an exciting time for the life sciences industry. Around the world, companies in the sector are looking to transform and innovate their strategies as they adapt to various health care reforms and the evolving industry landscape. New solutions will be required to meet the global challenges of sustainability of health care systems, aging populations, chronic disease and increasing cost pressures. I look forward to working with our team of dedicated professionals to help our clients respond to these and other challenges.”
Pamela succeeds Glen Giovannetti, who has been appointed to the role of Research and Insights Leader, EY Knowledge. In this role, Glen will work with the EY Knowledge team to create insights and thought leadership to accelerate access to information, insights and content for clients and other market stakeholders. He will also continue to advise EY clients as lead in the biotechnology subsector.
About EY
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.
This news release has been issued by EYGM Limited, a member of the global EY organization that also does not provide any services to clients.
How EY’s Global Life Sciences Sector can help your business
Life sciences companies — from emerging start-ups to multinational enterprises — face new challenges in a rapidly changing health care ecosystem. Payers and regulators are increasing scrutiny and accelerating the transition to value and outcomes. Big data and patient-empowering technologies are driving new approaches and enabling transparency and consumerism. Players from other sectors are entering health care, making collaborations increasingly complex. These trends challenge every aspect of the life sciences business model, from R&D to marketing. Our Global Life Sciences Center brings together a worldwide network — more than 7,000 sector-focused assurance, tax, transaction and advisory professionals — to anticipate trends, identify implications and develop points of view on responding to critical issues. We can help you navigate your way forward and achieve success in the new ecosystem.
Pamela assumes her new role with nearly 20 years’ experience working with clients across the life sciences and health care sectors. Since joining EY in 1998, she has held leadership positions in Transaction Advisory Services within the health sciences and technology sectors. During this time she led multinational transactions, acquisitions, disposals and IPOs, in addition to holding roles in business development with a focus on the life sciences sector. Prior to this appointment, Pamela was the global lead partner for some of EY’s largest multinational life sciences clients.
With a background in organic chemistry, earning a BSc (Hons) in Chemistry from the University of Nottingham, UK, Pamela is a qualified chartered accountant and has also attended INSEAD and Northwestern University's Kellogg School of Management.
Within this role, Pamela will continue to serve on the EY Global Accounts Committee, which is responsible for setting the strategic direction of the global organization's largest multinational clients across all industry sectors. Throughout her career at EY Pamela has distinguished herself as a passionate leader and as an advocate for diversity and inclusiveness, and these qualities will help to ensure a smooth transition as she moves into her new role. She will continue to be based in London.
Pamela Spence, EY Global Life Sciences Industry Leader, says: the life sciences sector. Prior to this appointment, Pamela was the global lead partner for some of EY’s largest multinational life sciences clients.
With a background in organic chemistry, earning a BSc (Hons) in Chemistry from the University of Nottingham, UK, Pamela is a qualified chartered accountant and has also attended INSEAD and Northwestern University's Kellogg School of Management.
Within this role, Pamela will continue to serve on the EY Global Accounts Committee, which is responsible for setting the strategic direction of the global organization's largest multinational clients across all industry sectors. Throughout her career at EY Pamela has distinguished herself as a passionate leader and as an advocate for diversity and inclusiveness, and these qualities will help to ensure a smooth transition as she moves into her new role. She will continue to be based in London.
Pamela Spence, EY Global Life Sciences Industry Leader, says:
“This is an exciting time for the life sciences industry. Around the world, companies in the sector are looking to transform and innovate their strategies as they adapt to various health care reforms and the evolving industry landscape. New solutions will be required to meet the global challenges of sustainability of health care systems, aging populations, chronic disease and increasing cost pressures. I look forward to working with our team of dedicated professionals to help our clients respond to these and other challenges.”
Pamela succeeds Glen Giovannetti, who has been appointed to the role of Research and Insights Leader, EY Knowledge. In this role, Glen will work with the EY Knowledge team to create insights and thought leadership to accelerate access to information, insights and content for clients and other market stakeholders. He will also continue to advise EY clients as lead in the biotechnology subsector.
About EY
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.
This news release has been issued by EYGM Limited, a member of the global EY organization that also does not provide any services to clients.
How EY’s Global Life Sciences Sector can help your business
Life sciences companies — from emerging start-ups to multinational enterprises — face new challenges in a rapidly changing health care ecosystem. Payers and regulators are increasing scrutiny and accelerating the transition to value and outcomes. Big data and patient-empowering technologies are driving new approaches and enabling transparency and consumerism. Players from other sectors are entering health care, making collaborations increasingly complex. These trends challenge every aspect of the life sciences business model, from R&D to marketing. Our Global Life Sciences Center brings together a worldwide network — more than 7,000 sector-focused assurance, tax, transaction and advisory professionals — to anticipate trends, identify implications and develop points of view on responding to critical issues. We can help you navigate your way forward and achieve success in the new ecosystem.